top of page

Q1 warning letter roundup with Asa Waldstein

Asa Waldstein

Apr 3, 2023

In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements.

​

bottom of page